Maa: Uusi-Seelanti
Kieli: englanti
Lähde: Medsafe (Medicines Safety Authority)
Fluconazole 50mg (polymorph Form II)
Multichem NZ Limited
Fluconazole 50 mg (polymorph Form II)
50 mg
Capsule
Active: Fluconazole 50mg (polymorph Form II) Excipient: Colloidal silicon dioxide Gelatin Iron oxide yellow Lactose monohydrate Magnesium stearate Microcrystalline cellulose Patent blue V Pregelatinised maize starch Quinoline yellow Sodium laurilsulfate Titanium dioxide
Blister pack, PVC and Aluminium, 28 capsules
Prescription
Prescription
Mylan Laboratories Limited
Cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary and cutaneous). Normal hosts, and patients with AIDS, organ transplants or other causes of immunosuppression may be treated. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with AIDS.
Package - Contents - Shelf Life: Blister pack, PVC and Aluminium - 28 capsules - 48 months from date of manufacture stored at or below 25°C protect from light and moisture
2003-05-22
_M-_ FLUCONAZOLE FLUCONAZOLE 50MG, 100MG, 150MG AND 200MG CAPSULES FLUCONAZOLE 2MG/ML SOLUTION FOR IV INFUSION FLUCONAZOLE Fluconazole is a bis-triazole: 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol. It has the following structural formula: CAS 86386-73-4 C 13 H 12 F 2 N 6 O PRESENTATION _m-_Fluconazole 50mg capsules are size 2 green and white capsules typically weighing 180.5mg. Each capsule contains 50mg fluconazole. _m-_Fluconazole 100mg capsules are size 1 buff coloured capsules typically weighing 310mg. Each capsule contains 100mg fluconazole. _m-_Fluconazole 150mg capsules are size 0 yellow capsules typically weighing 445.6mg. Each capsule contains 150mg fluconazole. _m-_Fluconazole 200mg capsules are size 0 white capsules typically weighing 562mg. Each capsule contains 200mg fluconazole. _m-_Fluconazole 2mg/ml solution for IV infusion is a clear colourless solution containing 2mg/ml fluconazole in 0.9% saline solution. Each 25ml vial contains 50mg fluconazole, each 50ml vial contains 100mg fluconazole and each 100ml vial contains 200mg Fluconazole. USES _ACTIONS _ Fluconazole, a member of a new class of triazole antifungal agents, is a potent and specific inhibitor of fungal sterol synthesis. Fluconazole, both orally and intravenously administered, is active in a variety of animal fungal infection models. Activity has been demonstrated against opportunistic mycoses, such as infections with _Candida_ spp, including systemic candidiasis and in immunocompromised animals; with _Cryptococcus neoformans,_ including intracranial infections, with _Microsporum_ spp; and with _Trichophyton_ spp. Fluconazole has also been shown to be active in animal models of endemic mycoses, including infections with _Blastomyces dermatitidis_; with _Coccidioides immitis,_ including intracranial infection; and with _Histoplasma capsulatum_ in norma Lue koko asiakirja